| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.036 | 0.9 |